PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A copy of the letter can be ...
Since launching AVISE CTD in 2012, Exagen has produced an extensive body of peer-reviewed literature supporting the test’s clinical validity and utility. These publications and the 1,000,000 th ...
Full Circles Therapeutics ("Full Circles"), a leader in next-generation cell and gene therapies, today announced the publication of a groundbreaking study in Nature Biotechnology. The paper, titled ...
Organically Human on MSN4h
Two Billion People Have a Brain Parasite – Here's Why Many Haven't NoticedMore than two billion people around the world are infected with a brain parasite called Toxoplasma gondii. This parasite is ...
In Philadelphia’s Norris Square neighborhood, Shannon Turner, a celebrated singer, vocal coach, and founder of the band ...
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria.
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria. When such ...
Cyrus Biotechnology announces potent in vivo redosability of an engineered IdeS protease for IgG-driven autoimmune disease.
Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they were foreign invaders. This widespread category of illnesses, such as ...
By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.
In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...
Type 1 Diabetes is a lifelong autoimmune condition that prevents a person’s pancreas from producing insulin, the hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback